Literature DB >> 23674209

The isotope bone scan: we can do better.

Ignac Fogelman, Glen M Blake, Gary J R Cook.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23674209     DOI： 10.1007/s00259-013-2439-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  18 in total

1.  Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer.

Authors:  H Schirrmeister; G Glatting; J Hetzel; K Nüssle; C Arslandemir; A K Buck; K Dziuk; A Gabelmann; S N Reske; M Hetzel
Journal:  J Nucl Med       Date:  2001-12       Impact factor: 10.057

2.  The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate.

Authors:  Vincent Helyar; Hosahalli K Mohan; Tara Barwick; Lefteris Livieratos; Gopinath Gnanasegaran; Susan E M Clarke; Ignac Fogelman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-17       Impact factor: 9.236

3.  Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT.

Authors:  Daisuke Utsunomiya; Shinya Shiraishi; Masanori Imuta; Seiji Tomiguchi; Koichi Kawanaka; Shoji Morishita; Kazuo Awai; Yasuyuki Yamashita
Journal:  Radiology       Date:  2005-11-22       Impact factor: 11.105

4.  Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases.

Authors:  Robert K Doot; Mark Muzi; Lanell M Peterson; Erin K Schubert; Julie R Gralow; Jennifer M Specht; David A Mankoff
Journal:  J Nucl Med       Date:  2010-03-17       Impact factor: 10.057

5.  Radionuclide studies of bone metabolism: do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover?

Authors:  Glen M Blake; Musib Siddique; Michelle L Frost; Amelia E B Moore; Ignac Fogelman
Journal:  Bone       Date:  2011-06-13       Impact factor: 4.398

6.  The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.

Authors:  Einat Even-Sapir; Ur Metser; Eyal Mishani; Gennady Lievshitz; Hedva Lerman; Ilan Leibovitch
Journal:  J Nucl Med       Date:  2006-02       Impact factor: 10.057

7.  Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations.

Authors:  Carolin Reischauer; Johannes M Froehlich; Dow-Mu Koh; Nicole Graf; Christian Padevit; Hubert John; Christoph A Binkert; Peter Boesiger; Andreas Gutzeit
Journal:  Radiology       Date:  2010-09-09       Impact factor: 11.105

8.  F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management.

Authors:  Martin Hetzel; Coskun Arslandemir; Hans-Helmut König; Andreas K Buck; Karin Nüssle; Gerhard Glatting; Andreas Gabelmann; Jürgen Hetzel; Vinzenz Hombach; Holger Schirrmeister
Journal:  J Bone Miner Res       Date:  2003-12       Impact factor: 6.741

9.  The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT.

Authors:  Mohsen Beheshti; Reza Vali; Peter Waldenberger; Friedrich Fitz; Michael Nader; Josef Hammer; Wolfgang Loidl; Christian Pirich; Ignac Fogelman; Werner Langsteger
Journal:  Mol Imaging Biol       Date:  2009 Nov-Dec       Impact factor: 3.488

10.  Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study.

Authors:  Mohsen Beheshti; Reza Vali; Peter Waldenberger; Friedrich Fitz; Michael Nader; Wolfgang Loidl; Gabriele Broinger; Franz Stoiber; Ignac Foglman; Werner Langsteger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-09       Impact factor: 9.236
View more
  3 in total

Review 1.  Molecular imaging agents for SPECT (and SPECT/CT).

Authors:  Gopinath Gnanasegaran; James R Ballinger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-12-07       Impact factor: 9.236

2.  Diet and 18F bone imaging.

Authors:  V Ralph McCready; Sabina Dizdarevic
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-27       Impact factor: 9.236

3.  68Ga-PSMA-PET/CT in comparison with 18F-fluoride-PET/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer: a prospective diagnostic accuracy study.

Authors:  Eva Dyrberg; Helle W Hendel; Tri Hien Viet Huynh; Tobias Wirenfeldt Klausen; Vibeke B Løgager; Claus Madsen; Erik M Pedersen; Maria Pedersen; Henrik S Thomsen
Journal:  Eur Radiol       Date:  2018-08-21       Impact factor: 5.315
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.